HomeVNDA • NASDAQ
add
Vanda Pharmaceuticals Inc.
Previous close
$4.68
Day range
$4.70 - $4.91
Year range
$3.30 - $7.00
Market cap
284.01M USD
Avg Volume
3.84M
P/E ratio
111.95
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 45.27M | -29.79% |
Operating expense | 48.90M | -5.25% |
Net income | -2.40M | -134.98% |
Net profit margin | -5.30 | -149.81% |
Earnings per share | — | — |
EBITDA | -5.94M | -181.40% |
Effective tax rate | -44.49% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 388.26M | -16.83% |
Total assets | 648.44M | 2.24% |
Total liabilities | 103.53M | -3.29% |
Total equity | 544.91M | — |
Shares outstanding | 57.54M | — |
Price to book | 0.49 | — |
Return on assets | -2.75% | — |
Return on capital | -3.20% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.40M | -134.98% |
Cash from operations | -3.73M | -139.63% |
Cash from investing | -43.78M | -158.05% |
Cash from financing | — | — |
Net change in cash | -47.36M | -155.31% |
Free cash flow | -105.34M | -1,964.32% |
About
Founded
2002
Headquarters
Website
Employees
203